GHSI Guardion Health Sciences: Company Future Sales Volume

Guardion Health Science (GHSI) prospective sales dynamics demonstrate stagnation due to extreme saturation in the nutraceuticals market and rising marketing costs. The value of 0.01 represents the current figure for this metric. In contrast, Guardion Health Science (GHSI) is developing partnerships with ophthalmology centers for patient support, leveraging strong R&D potential in the fight against macular degeneration.

GHSI - Guardion Health Science Projected Sales Volume over the range 07/04/2022 - 10/19/2024

Guardion Health Sciences, Inc. (GHSI) - metric breakdowns and financial figures

- stock quotes and analyst forecast:

Stock Price Guardion Health Science|GHSI - Analyst Target Range

- company stock capitalization data:

Market Valuation Guardion Health Sciences Inc.|GHSI - Enterprise Value

- issuer book value statistics:

Book Value per Share Guardion Health Sciences|GHSI - Book Capitalization|Market Value to Book Value Ratio guardionhealth.com|GHSI - Aggregate Asset Value

- company liabilities and liquidity data:

Total Debt to Capital Guardion Health Science|GHSI - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Guardion Health Sciences Inc.|GHSI - Company Total Debt Obligations|Debt to Book Capitalization Ratio Guardion Health Sciences Inc.|GHSI - Long-Term Debt|Company Short-Term Debt Guardion Health Sciences|Quick Liquidity Indicator guardionhealth.com

- earnings and market ratios statistics:

GHSI - Final Profit|Projected Future Earnings Guardion Health Science|GHSI - Company Value to Net Income|Forward P/E Multiple Guardion Health Sciences|GHSI - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Guardion Health Sciences Inc.|GHSI - Operating profit EBITDA|Earnings per share for the last twelve months Guardion Health Sciences|GHSI - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months guardionhealth.com|GHSI - Net earnings per one share growth for the current year|Earnings growth forecast for next year Guardion Health Science

- sales volume and revenue indicators:

GHSI - Company Sales Revenue|Company Future Sales Volume Guardion Health Science|GHSI - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Guardion Health Sciences Inc.

Basic company analysis:GHSI Guardion Health Science

Guardion Health Science develops innovative nutraceuticals to combat macular degeneration. This indicator captures the real-time capital revaluation by institutional players based on new corporate data. It measures the shift in the business's fundamental value, reflecting the consensus forecast of future cash flows. It is critical for investors to distinguish long-term R&D potential growth from short-term news noise. Analyzing the trend of the firm's future sales allows for the minimization of costs during portfolio rebalancing.

Competitors of Guardion Health Science (GHSI)

Projected Sales Volume ALC|bausch.com (BLCO) - Company Sales Forecast|Glaukos - Company Future Sales Volume|Projected Sales Volume Apellis Pharmaceuticals, Inc. APLS|Belite Bio Pharma - Projected Sales Volume|OCUL - Projected Sales Volume|Harrow, Inc. (HROW) - Company Projected Revenue|viridiantherapeutics.com - Company Future Revenue|LENZ (LENZ Therapeutics) - Projected Sales Volume|Company Revenue Forecast OCS (Oculis Holding)|Projected Sales Volume EYPT|Company Future Sales Kodiak Corp|Company Projected Revenue Aldeyra Therapeutics, Inc. ALDX|KALA BIO Inc. (KALA) - Company Expected Sales Volume|IRD - Company Projected Revenue|OKYO (OKYO Pharma Limited) - Company Revenue Forecast|ADVM (adverum.com) - Company Future Sales Volume|Outlook Therapeutics Corp - Company Future Revenue|CLSD (Clearside Biomedical) - Projected Sales Volume|NBY: Company Future Revenue|Projected Sales Volume KPRX|ALIM - Company Expected Sales Volume|Projected Sales Volume EYEN (Eyenovia)|Projected Sales Volume Ocuphire Corporation OCUP|OPT - Company Projected Revenue